Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failureDanielle Rasooly, Juan P. Casas, A. Patrícia Bento et al.|Nature Communications|2023Cited by 130
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fractionDanielle Rasooly, Jacob Joseph, Claudia Giambartolomei et al.|Nature Cardiovascular Research|2025Cited by 19
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failureDanielle Rasooly, Juan P. Casas, Gina M. Peloso et al.|medRxiv|2022Cited by 10
Leveraging Large-Scale Biobanks for Therapeutic Target DiscoveryBrian R. Ferolito, Alexandre C. Pereira, Hesam Dashti et al.|medRxiv|2025Cited by 4
Large-scale Mendelian randomization identifies novel pathways as therapeutic targets for heart failure with reduced ejection fraction and with preserved ejection fractionDanielle Rasooly, Juan P. Casas, Claudia Giambartolomei et al.|medRxiv|2024Cited by 0